首页    期刊浏览 2024年11月24日 星期日
登录注册

文章基本信息

  • 标题:Differential Cytotoxicity of Anticancer Agents in Pre- and Post-Immortal Lymphoblastoid Cell Lines
  • 本地全文:下载
  • 作者:Kaori Sawada ; Keisuke Noda ; Hiroto Nakajima
  • 期刊名称:Biological and Pharmaceutical Bulletin
  • 印刷版ISSN:0918-6158
  • 电子版ISSN:1347-5215
  • 出版年度:2005
  • 卷号:28
  • 期号:7
  • 页码:1202-1207
  • DOI:10.1248/bpb.28.1202
  • 出版社:The Pharmaceutical Society of Japan
  • 摘要:We studied the cytotoxic effect of various anticancer agents on lymphoblastoid cell lines transformed by Epstein–Barr virus. Post-immortal N0005 (post-N0005) is an immortalized cell line derived from pre-immortal N0005 (pre-N0005) accompanied by increased telomerase activity, short-telomere, abnormal karyotypes, mutation of p53 gene, down regulation of p16/Rb and the ability to grow in soft agar medium. Compared with pre-N0005 cells, post-N0005 cells were significantly ( p <0.001 by the Student t test) more resistant to the killing activity of seven DNA-modifying agents: camptothecin, etoposide, bleomycin, fluorouracil, thioguanine, melphalan and actinomycin D. However, both pre-N0005 and post-N0005 cells showed similar levels of cytotoxicity against four DNA-non-modifying agents: colchicine, paclitaxel, vincristine and methotrexate. DNA-modifying and DNA-non-modifying agents are distinguished by their different sensitivities with pre-N0005 and post-N0005. Based on these results, we propose that pre-N0005 and post-N0005 cell lines be used as a new method to assess and screen anticancer agents.
  • 关键词:anticancer agent;assessment;screening;immortalized cell line;DNA-modifying agent
国家哲学社会科学文献中心版权所有